Castle Biosciences CSTL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $63.76M-45.4% | $116.73M+36.4% | $85.56M+4.0% | $82.23M-8.3% | $89.69M-25.1% | ||
| $5.6M+0.1% | $5.59M+0.1% | $5.58M-97.0% | $184.81M+0.8% | $183.33M— | ||
| $42.26M-2.6% | $43.38M-12.3% | $49.48M-5.4% | $52.31M-7.2% | $56.35M+10.0% | ||
| $10.46M+2.0% | $10.25M+18.5% | $8.65M+3.4% | $8.37M+22.1% | $6.85M-15.8% | ||
| $328.9M-8.9% | $361.1M+1.0% | $357.57M+2.6% | $348.67M-0.2% | $349.39M-3.0% | ||
| $100.93M+3.6% | $97.44M+14.8% | $84.89M+14.6% | $74.06M+33.6% | $55.42M+8.4% | ||
| $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | $10.7M0.0% | ||
| $86.66M-2.5% | $88.88M-2.5% | $91.16M-2.4% | $93.43M+39.0% | $67.21M-29.6% | ||
| $547.81M-5.3% | $578.56M+2.8% | $562.79M+3.3% | $544.73M+8.6% | $501.72M-5.6% | ||
| $15.04M-19.6% | $18.71M+53.2% | $12.21M-7.4% | $13.18M+55.0% | $8.5M+23.2% | ||
| $1.67M+300% | $417K— | $0-100% | $1.94M+75.0% | $1.11M+300% | ||
| $48.76M-29.0% | $68.68M+24.2% | $55.31M+8.7% | $50.89M+36.5% | $37.27M-24.5% | ||
| $8.4M-12.9% | $9.64M-4.1% | $10.05M+24.1% | $8.1M-9.2% | $8.92M-8.5% | ||
| $86.39M-19.8% | $107.68M+12.5% | $95.74M+7.1% | $89.35M+45.5% | $61.41M-18.6% | ||
| $30K0.0% | $30K+3.4% | $29K0.0% | $29K0.0% | $29K+3.6% | ||
| -$238.81M-6.5% | -$224.28M-1.1% | -$221.95M-0.2% | -$221.45M+2.0% | -$225.97M-12.9% | ||
| $461.42M-2.0% | $470.87M+0.8% | $467.05M+2.6% | $455.38M+3.4% | $440.31M-3.4% | ||
| $547.81M-5.3% | $578.56M+2.8% | $562.79M+3.3% | $544.73M+8.6% | $501.72M-5.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Castle Biosciences's total assets?
- Castle Biosciences (CSTL) holds $547.8M in total assets, up 9.2% year over year.
- How much debt does Castle Biosciences have?
- Castle Biosciences carries $36.7M in total debt against $461.4M of shareholders' equity, a debt-to-equity ratio of 0.08.
- How much cash does Castle Biosciences have?
- Castle Biosciences holds $63.8M in cash and equivalents.
- Can Castle Biosciences cover its short-term obligations?
- Its current ratio is 6.75 — current assets exceed current liabilities.
- Where does Castle Biosciences's balance sheet data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
